Hisamitsu Pharmaceutical and Kyowa Hakko Kirin sign Commercialization Agreement for HP-3000, a Potential New Transdermal Patch for Parkinson’s Disease in Japan
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://www.kyowakirin.com/media_center/news_releases/2019/pdf/e20190205_08.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (2)
Alternatively, you can try searching for similar contracts:
